A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
Clinical trial NCT06795048 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06795048
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-14
- Primary completion
- 2026-10-20
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.